This article investigates the gap in access to and quality of mental health care in the United
States. This work first discusses how minority populations are most affected by the treatment …

We conducted a systematic review of meta-analyses and systematic reviews to evaluate the
impact of cannabis use on the onset and course of psychoses. Following a systematic …

The current management of patients with primary psychosis worldwide is often remarkably
stereotyped. In almost all cases an antipsychotic medication is prescribed, with second …

The goal of this guideline is to improve the quality of care and treatment outcomes for
patients with schizophrenia, as defined by the Diagnostic and Statistical Manual of Mental …

Background Cannabis legalization has enabled increased consumption in older adults. Age-
related mental, physical, and physiological changes may lead to differences in effects of …

Background: Schizophrenia is among the major causes of disability worldwide and the
mortality from cardiovascular disease (CVD) is significantly elevated. There is a growing …

''Is my son at risk in view of COVID-19?''A patient's mother contacted our Schizophrenia
Outpatient Clinic as soon as news about the coronavirus pandemic reached Brazilian …

We examined prevalence, treatment patterns, trends, and correlates of mental health and
substance use treatments among adults with co-occurring disorders. Our data were from the …

Researchers have repeatedly observed that clinicians diagnose Black individuals with
schizophrenia at greater rates than White individuals. We conducted a meta-analytic review …

Purpose The present study established the national prevalence of substance use disorders
(SUDs) among Danish psychiatric patients. Furthermore, patients with SUDs and those …